![Woo-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 19 735 $ op 31-05-2026
Woo-Jin Kim formerly worked at KB Insurance Co., Ltd., as President & Co-Chief Executive Officer and SAMSUNG PHARMACEUTICAL Co., Ltd., as Independent Director.
Mr. Kim received his graduate degree from Seoul National University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENOLUTION, Inc.
 GENOLUTION, Inc. BiotechnologyHealth Technology Develops new drugs 0,09% | 09-06-2026 | 17.640 ( 0,09% ) | 19 735 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SAMSUNG PHARM. CO., LTD. | Directeur/Bestuurslid | - |
| KB INSURANCE CO LTD | President | 04-07-2012 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
KB Insurance Co., Ltd.
 KB Insurance Co., Ltd. Multi-Line InsuranceFinance Operates as a non-life insurance carrier | Finance |
SAMSUNG PHARMACEUTICAL Co., Ltd.
 SAMSUNG PHARMACEUTICAL Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
